ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK

NCT03287271 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: VS-6063
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

Michael McHale

Collaborators

[object Object]
[object Object]